Clinical differences between Raoultella spp. and Klebsiella oxytoca
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1260212 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Sofia K Mettler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Klebsiella oxytoca, Enterobacteriaceae, Klebsiella Infections, Anti-Bacterial Agents. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Raoultella spp. is a genus of bacteria that is known to be closely related to Klebsiella . It has been debated whether Raoultella should be reclassified as a subgroup of Klebsiella . The aim of this study is to compare clinical aspects of Raoultella and Klebsiella oxytoca , a species of Klebsiella that is known to be bacteriologically similar to Raoultella spp.
Methods
Using data collected at a tertiary care hospital in the United States, we identified 43 patients with Raoultella infection and 1173 patients with Klebsiella oxytoca infection. We compared patient demographics (age and sex), hospitalization status, isolation sites and antibiotic resistance profiles between the two species.
Results
There was no significant difference in patient demographics between the two bacteria species. The proportions of intensive care unit (ICU) admission were higher among patients with Raoultella infection (p=0.008). The most common site of isolation was urine for both species (39.5% of all patients with Raoultella spp. vs. 59.3% for K. oxytoca ). The second most common site of isolation was blood stream for Raoultella spp. (23.3%) and respiratory tract for K. oxytoca (10.8%). Except for the high proportion of resistant isolates of Raoultella spp. for Trimethoprim/sulfamethoxazole, the antibiotic susceptibility profiles were similar between the two bacteria species. Both were susceptible to ciprofloxacin and meropenem.
Conclusion
While there are no significant differences in the patient demographics and antibiotic susceptibility profiles between Raoultella spp. and K. oxytoca , Raoultella may cause more serious infection requiring ICU admissions. Also, Raoultella may cause blood stream infection more frequently than K. oxytoca .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
- Department of Medicine, Mount Auburn Hospital, Cambridge, MA, United States.
- Harvard Medical School, Boston, MA, United States.
- Mahidol University, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.
Zitieren
APA
Mettler, S. K., Charoenngam, N., & Colgrove, R. C. (2024). Clinical differences between Raoultella spp. and Klebsiella oxytoca. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1260212
Vancouver
Mettler SK, Charoenngam N, Colgrove RC. Clinical differences between Raoultella spp. and Klebsiella oxytoca. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1260212
BibTeX
@article{Mettler2024,
author = {Mettler, Sofia K and Charoenngam, Nipith and Colgrove, Robert C},
title = {Clinical differences between Raoultella spp. and Klebsiella oxytoca},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1260212}
}
EUVIMED